SCHEMBL4887026

SCHEMBL4887026

O=C1c2ccccc2C(=O)N1CCc1ccccc1C=C[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 2/20 0.43
GAA P10253 2/20 0.43
NPC1 O15118 1/20 0.43
RXRA P19793 1/20 0.42
CASP3 P42574 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA9 Q16790 1/20 0.41
HSD17B10 Q99714 1/20 0.40
TLR4 O00206 1/20 0.40
TLR2 O60603 1/20 0.40
GLS O94925 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13979638 1.00 MAPT (0.43) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL4656546 0.78 GAA (0.50) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL13979631 0.78 MAPT (0.45) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL6675068 0.77 ALDH1A1 (0.61) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL13915431 0.75 RXRA (0.50) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL4621752 0.75 RXRA (0.50) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL28409911 0.75 RXRA (0.50) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL28409564 0.75 RXRA (0.50) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL10398562 0.70 CASP3 (0.47) ALDH1A1CASP3CA9GLSHTT
SCHEMBL13979654 0.69 GAA (0.42) MAPTALDH1A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378439-B2 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride USV, LTD. (IN) 2008-05-27 US disclosed
US-20050159605-A1 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride USV LIMITED (IN) 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159605-A1 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride PARK7, SNCA, TPH1 MAPT 95/4885ALDH1A1 351/4885MEN1 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.